<!DOCTYPE html>
<!--[if lt IE 9]><html class="no-js lt-ie9" lang="en" dir="ltr"><![endif]-->
<!--[if gt IE 8]><!-->
<html class="no-js" lang="en" dir="ltr">
<!--<![endif]-->

<head>
	<meta charset="utf-8">
	<!-- Web Experience Toolkit (WET) / Boîte à outils de l'expérience Web (BOEW) wet-boew.github.io/wet-boew/License-en.html / wet-boew.github.io/wet-boew/Licence-fr.html -->
	<title>COVID-19 Vaccine and drug progress tracker - Canada.ca</title>
	<meta content="width=device-width,initial-scale=1" name="viewport">
	<!-- Meta data -->
	<!-- Meta data-->
	<!-- Load closure template scripts -->
	<script type="text/javascript"
		src="https://www.canada.ca/etc/designs/canada/cdts/gcweb/v4_0_30/cdts/compiled/soyutils.js"></script>
	<script type="text/javascript"
		src="https://www.canada.ca/etc/designs/canada/cdts/gcweb/v4_0_30/cdts/compiled/wet-en.js"></script>
	<link href="https://test.canada.ca/covid-19-guidance/proto/css/alpha-beta-banner.css" rel="stylesheet">
	<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.8.1/css/all.css"
		integrity="sha384-50oBUHEmvpQ+1lW4y57PTFmhCaXp0ML5d60M1M7uH2+nqUivzIebhndOJK28anvf" crossorigin="anonymous" />

	<!-- Write closure template -->
	<script type="text/javascript">
		document.write(wet.builder.refTop({
		}));
	</script>
</head>

<body vocab="http://schema.org/" typeof="WebPage">
	<div id="def-top">
	</div>
	<!-- Write closure template -->
	<script type="text/javascript">
		var defTop = document.getElementById("def-top");
		defTop.outerHTML = wet.builder.top({
			lngLinks: [{
				lang: "fr",
				href: "travel-advice-fr.html",
				text: "Français"
			}],
			breadcrumbs: [{
				title: "Home",
				href: "https://www.canada.ca/en.html"
			}, {
				title: "Health",
				href: "https://www.canada.ca/en/services/health.html"
			}, {
				title: "Diseases and conditions",
				href: "https://www.canada.ca/en/public-health/services/diseases.html"
			}, {
				title: "Coronavirus (COVID-19)",
				href: "landing.html"
			}],
			search: true,
			siteMenu: true,
			showPreContent: true
		});
	</script>
	<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.8.1/css/all.css"
		integrity="sha384-50oBUHEmvpQ+1lW4y57PTFmhCaXp0ML5d60M1M7uH2+nqUivzIebhndOJK28anvf" crossorigin="anonymous" />

	<main role="main" property="mainContentOfPage" class="container">

		<h1 property="name" id="wb-cont" dir="ltr">Drugs and vaccines for COVID-19: Progress tracker <br> </h1>

		<div class="row">

			<div class="col-md-6 pull-right mrgn-tp-lg panel panel-default">
				<p class="mrgn-tp-md"><span class="text-info h2">77%</span> of Canadians report they are likely to get a
					<span class="no-break"></span>COVID-19 vaccination when it's available.</p>
				<p><strong>Source:</strong> <a
						href="https://www150.statcan.gc.ca/n1/pub/45-28-0001/2020001/article/00073-eng.htm">Statistics
						Canada - Canadians' willingness to get a COVID-19 vaccine</a></p>
			</div>
			<div class="col-md-6 pull-left">
				<h2>On this page</h2>
				<ul>
					<li><a href="#a1">Securing potential vaccines and supplies</a></li>
					<li><a href="#a2">Vaccination roll-out preparedness</a></li>
					<li><a href="#a3">Drug and treatment progress in Canada</a></li>
					<li><a href="#a4">Government funding for vaccine and treatment research</a></li>
					<li><a href="#a5">Vaccines are safe to use and crucial to protecting Canadians</a></li>
				</ul>
			</div>

		</div>

		<section class="well well-sm brdr-0 mrgn-bttm-0">
			<div class="container-fluid mrgn-tp-sm mrgn-bttm-sm">
				<h2 id="a1" class="mrgn-tp-0">Securing potential vaccines and supplies</h2>
				<p>To date, Canada has invested over $1 billion in vaccine agreements. All Canadians can rest assured that a safe and effective	vaccine will be available to them – for free – once it is ready. </p>

				<p>The government has put in place an agile process that allows for review on a rolling basis. Health Canada's scientific reviewers are already evaluating data for at least 3 vaccines. This will ensure promising vaccine candidates receive timely review and authorization when found to be safe and effective. </p>
				<div class="row mrgn-bttm-sm">
					<div class="col-xs-12 mrgn-tp-sm">

						<h3 class="pull-left mrgn-tp-0 h3 text-info" id="agreements">Agreements for potential vaccines
							and human trial status</h3>
						<div class="clearfix"></div>

						<table class="table table-striped table-hover table-responsive small">
							<thead>
								<tr>
									<th scope="col">Supplier</th>
									<th scope="col">Doses</th>
									<th scope="col">Human trials</th>
									<th scope="col">Vaccine at Clinicaltrials.gov</th>
									<th scope="col">Authorization in Canada</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td>AstraZeneca</td>
									<td>Up to 20 million </td>
									<td>Phases:<span class="label label-info">3</span></td>
									<td><a href="https://clinicaltrials.gov/ct2/results?cond=&term=AZD1222">AZD1222</a>
									</td>
									<td><span class="label label-default">None</span></td>
								</tr>
								<tr>
									<td>Johnson and Johnson</td>
									<td>Up to 38 million</td>
									<td>Phases:<span class="label label-info">1</span><span
											class="label label-info">2</span><span class="label label-info">3</span>
									</td>
									<td><a
											href="https://clinicaltrials.gov/ct2/results?cond=&term=Ad26.COV2.S">Ad26.COV2.S</a>
									</td>
									<td><span class="label label-default">None</span></td>
								</tr>
								<tr>
									<td>Medicago <span class="fab fa-canadian-maple-leaf" style="color:#af3c43;"></span>
									</td>
									<td>Up to 76 million</td>
									<td>Phases:<span class="label label-info">1</span><span
											class="label label-info">2</span><span class="label label-info">3</span>
									</td>
									<td><a
											href="https://clinicaltrials.gov/ct2/results?cond=&term=Recombinant+Coronavirus-Like+Particle&cntry=CA&state=&city=&dist=">Coronavirus-Like
											Particle</a></td>
									<td><span class="label label-default">None</span></td>
								</tr>
								<tr>
									<td>Moderna</td>
									<td>Up to 56 million</td>
									<td>Phases:<span class="label label-info">1</span><span
											class="label label-info">2</span><span class="label label-info">3</span>
									</td>
									<td><a
											href="https://clinicaltrials.gov/ct2/results?cond=&term=mRNA-1273">mRNA-1273</a>
									</td>
									<td><span class="label label-default">None</span></td>
								</tr>
								<tr>
									<td>Novavax</td>
									<td> Up to 76 million</a></td>
									<td>Phases:<span class="label label-info">1</span><span
											class="label label-info">2</span><span class="label label-info">3</span>
									</td>
									<td><a
											href="https://clinicaltrials.gov/ct2/results?cond=&term=NVX-CoV2373">NVX-CoV2373</a>
									</td>
									<td><span class="label label-default">None</span></td>
								</tr>
								<tr>
									<td>Pfizer</td>
									<td>Up to 76 million</a></td>
									<td>Phases:<span class="label label-info">1</span><span
											class="label label-info">2</span><span class="label label-info">3</span>
									</td>
									<td><a href="https://clinicaltrials.gov/ct2/results?cond=&term=BNT162">BNT162</a>
									</td>
									<td><span class="label label-default">None</span></td>
								</tr>
								<tr>
									<td>Sanofi and GlaxoSmithKline</td>
									<td>Up to 72 million</a></td>
									<td>Phases:<span class="label label-info">1</span><span
											class="label label-info">2</span></td>
									<td><a
											href="https://clinicaltrials.gov/ct2/results?cond=&term=Recombinant+Protein+Vaccine+Formulations+Against+COVID-19">Protein
											subunit</a></td>
									<td><span class="label label-default">None</span></td>
								</tr>
							</tbody>
						</table>
						<p>To find out if you can participate in a COVID-19 vaccine trial in Canada, see Health Canada's <a
							href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/list-authorized-trials.html">List
							of authorized clinical trials.</a>
					</p>
					</div>
				</div>

				<h3 class="text-info">Vaccination roll-out preparedness</h3>
				<p>In preparation for vaccine roll-out, the government has invested $284.2 million to improve our capacity to distribute COVID-19 vaccines to Canadians. Actions include: </p>
				<ul>
					<li>Agreements to purchase syringes, alcohol swabs and other immunization supplies by<a href="https://www.tpsgc-pwgsc.gc.ca/comm/index-eng.html">Public Services and
						Procurement Canada</a></li>
					<li>Securing specialized freezer capacity to hold tens of millions of doses of specific vaccine candidates</li>
					<li><a
							href="https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/research-priorities-covid-19-vaccines.html#toc8">Planning</a> of options for shipping and storage of COVID-19 vaccines </li>
					<li><a href="https://www.canada.ca/en/public-health/news/2020/11/major-general-dany-fortin-assisting-government-of-canadas-vaccine-distribution-planning.html">Logistics planning by the Canadian Armed Forces and the Public Health Agency of Canada</a></li>
				</ul>
				<p>Rolling out vaccines will be a complex national endeavour. As part of continuing preparations for the distribution of a vaccine, Canada is working with provinces, territories, Indigenous partners and private sector partners to ensure the appropriate planning and infrastructure is in place to receive and deploy vaccines.</p>
				<p>Supported by: <a
						href="https://nrc.canada.ca/en/corporate/covid-19-vaccine-task-force">the COVID-19 Vaccine Task
						Force </a>, <a href="https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01780.html">the
						COVID-19 Therapeutics Task Force</a>, and the <a href="https://www.covid19immunitytaskforce.ca/">Immunity Task Force.</a> </p>
			</div>
		</section>
		<section class="well-sm">
			<div class="container-fluid mrgn-tp-sm mrgn-bttm-sm">
				<h2 id="a3">Drugs and treatment progress in Canada</h2>
				<p>There are many potential drugs being investigated in Canada and around the world for use against
					COVID-19. Drugs must meet the regulatory requirements for safety, efficacy and quality before they
					are authorized for use in Canada. Health Canada also monitors real-world evidence while they are on the market.</p>
				<h3 class="text-info" id="drugs-approved">Drugs authorized for the
					treatment of COVID-19</h3>
					<p>See Health Canada's<a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/list-drugs.html"> List of authorized drugs and expanded indications </a></p>

				<h3 class="text-info">Clinical trials of drugs in Canada </h2>
					<p>Potential COVID-19 drugs currently being investigated in authorized Canadian clinical trials
						include:</p>
					<ul>
						<li>antiviral drugs</li>
						<li>anti-malarial drugs</li>
						<li>monoclonal antibodies and other drugs that address inflammation</li>
						<li><a href="https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72957a-eng.php">convalescent
								plasma</a> collected from patients who have recovered from COVID-19</li>
						<li>medical gases</li>
					</ul>
					<p>See Health Canada's <a href="./drugs-vaccines-authorized-clinical-trials.html">List of authorized
							COVID-19 clinical trials</a></p>

			</div>
		</section>

		<section class="well well-sm brdr-0 mrgn-bttm-0">
			<div class="container-fluid mrgn-tp-sm mrgn-bttm-sm">
				<h2 id="a4" class="mrgn-tp-0">Government funding for vaccine and treatment research</h3>
					<p>Funding from Innovation Canada for the most promising options for safe, effective vaccines is
						being made available to vaccine and bio-manufacturing applications from domestic candidates
						reviewed by the COVID-19 Task Force.</p>


					<h3 class="text-info" id="confirm-registration">Funding early stage vaccines in Canada</h3>
					<div class="table-responsive">
						<table class="table table-striped table-hover table-responsive small">
							<thead>
								<tr>
									<th scope="col">Vaccine developer</th>
									<th scope="col">Vaccine</th>
									<th scope="col">Funding announcement</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td>IMV Inc.</td>
									<td>BNT162</td>
									<td><a
											href="https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html">Multiple
											sources</a></td>
								</tr>
								<tr>
									<td>Medicago</td>
									<td>Coronavirus-like particle</td>
									<td><a
											href="https://pm.gc.ca/en/news/news-releases/2020/10/23/prime-minister-announces-funding-advance-development-canadian-covid">Strategic
											Innovation Fund</a></td>
								</tr>
								<tr>
									<td>Precision NanoSystems Inc.</td>
									<td>mRNA candidate</td>
									<td><a
											href="https://pm.gc.ca/en/news/news-releases/2020/10/23/prime-minister-announces-funding-advance-development-canadian-covid">Strategic
											Innovation Fund</a></td>
								</tr>
								<tr>
									<td>Variation Biotechnologies Inc.</a></td>
									<td>VBI-2900</td>
									<td><a
											href="https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html">Strategic
											Innovation Fund</sa>
									</td>
								</tr>
								<tr>
									<td>VIDO-Intervac</a></td>
									<td>Not named</td>
									<td><a
											href="https://pm.gc.ca/en/news/news-releases/2020/04/23/prime-minister-announces-new-support-covid-19-medical-research-and">Multiple
											sources</sa>
									</td>
								</tr>

							</tbody>
						</table>
					</div>


					<div class="row mrgn-bttm-md">
						<div class="col-xs-12">
							<h3 class="pull-left mrgn-tp-0 mrgn-lft-sm h3 text-info" id="confirm-registration">COVID-19
								basic vaccine research funding</h3>
							<div class="clearfix"></div>
							<div class="table-responsive">

								<p>The national medical research strategy to fight COVID-19 includes support for basic
									genetic and vaccine research and immunization strategies. </p>
								<table class="table table-striped table-hover table-responsive small">
									<thead>
										<tr>
											<th scope="col">Research activity</th>
											<th scope="col">Announcement date</th>
											<th scope="col">Vaccine projects</th>
											<th scope="col">Funding</th>
										</tr>
									</thead>
									<tbody>
										<tr>
											<td>Canadian Institutes of Health Research(CIHR)</td>
											<td><a href="https://cihr-irsc.gc.ca/e/51908.html">February 2020
													competition</a></td>
											<td><a
													href="https://webapps.cihr-irsc.gc.ca/decisions/p/main.html?lang=en#fq={!tag=competitioncd}competitioncd%3A202002OV5&sort=namesort%20asc&start=0&rows=20">6
													projects</a></td>
											<td><span class="label label-success">$5.1 million</span></td>
										</tr>
										<tr>
											<td>Canadian Institutes of Health Research(CIHR)</td>
											<td><a href="https://cihr-irsc.gc.ca/e/52013.html">May 2020 competition</a>
											</td>
											<td><a
													href="https://webapps.cihr-irsc.gc.ca/decisions/p/main.html?lang=en#fq={!tag=competitioncd}competitioncd%3A202005VR1&sort=namesort%20asc&start=0&rows=20">8
													projects</a></td>
											<td><span class="label label-success">$11.7 million</span></td>
										</tr>
										<tr>
											<td>Canadian Immunization Research Network</td>
											<td>April 2020</td>
											<td><a
													href="https://pm.gc.ca/en/news/news-releases/2020/04/23/prime-minister-announces-new-support-covid-19-medical-research-and">trials
													and monitoring</a></td>
											<td><span class="label label-success">$15.3 million</span></td>
										</tr>
									</tbody>
								</table>

								<h3 class="pull-left mrgn-tp-0 mrgn-lft-sm h3 text-info" id="drug">COVID-19 drug and
									therapeutic research funding</h3>
								<table class="table table-striped table-hover table-responsive small">
									<thead>
										<tr>
											<th scope="col">Research activity</th>
											<th scope="col">Announcement date</th>
											<th scope="col">Projects</th>
											<th scope="col">Funding</th>
										</tr>
									</thead>
									<tbody>
										<tr>
											<td>Canadian Institutes of Health Research(CIHR)</td>
											<td><a href="https://cihr-irsc.gc.ca/e/51908.html">February 2020 -
													Therapeutics</a></td>
											<td>18 projects</td>
											<td><span class="label label-success">$11.5 million</span></td>
										</tr>
										<tr>
											<td>Canadian Institutes of Health Research(CIHR)</td>
											<td><a href="https://cihr-irsc.gc.ca/e/52013.html">May 2020 -
													Therapeutics</a></td>
											<td>30 projects</td>
											<td><span class="label label-success">$35.1 million</span></td>
										</tr>
										</tr>
										<tr>
											<td>AbCellera</td>
											<td>May 3, 2020</td>
											<td><a
													href="https://www.canada.ca/en/innovation-science-economic-development/news/2020/05/minister-bains-announces-investment-in-antibody-discovery-technology-to-help-treat-covid-19.html">Antibody
													drugs</a></td>
											<td><span class="label label-success">$175.6 million</span></td>
										</tr>
										</tr>
									</tbody>
								</table>
							</div>
						</div>
						<p>Supported by: <a href="https://www.ic.gc.ca/eic/site/icgc.nsf/eng/home">Innovation, Science
								and Economic Development</a>, <a href="https://cihr-irsc.gc.ca/e/193.htmland"> Canadian
								Institutes of Health Research (CIHR)</a> ,<a
								href="https://nrc.canada.ca/en/corporate/covid-19-vaccine-task-force">the COVID-19
								Vaccine Task Force </a> and, <a
								href="https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01780.html">the COVID-19
								Therapeutics Task Force</a>.</p>
					</div>
			</div>
		</section>

		<section class="well-sm">
			<div class="container-fluid mrgn-tp-sm mrgn-bttm-sm">
				<h2 id="a5">Vaccines and drugs are safe to use and crucial to protecting Canadians</h2>
				<p>The Government of Canada has strict regulations and testing requirements to ensure that authorized
					vaccines and drugs are safe to use. We continue to monitor and assess the safety and effectiveness
					of a product once it is on the Canadian market
				</p>

				<ul>
					<li><a
							href="https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/fact-sheets/regulation-vaccines-human-canada.html">How
							the Government of Canada ensures vaccines are safe for use</a></li>
					<li><a href="http://www.icmra.info/drupal/strategicinitiatives/vaccines/statement_general_public">International
							statement about confidence in vaccines</a></li>
				</ul>
				<h3>Working with international partners to ensure vaccines are safe and widely adopted</h3>
				<p>Canada is working with <a
						href="https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/engaging-international-partners.html">international
						partners</a> on a coordinated and well-aligned approach to this global pandemic. This ensures
					that health products are safe, effective and quickly available to Canadians. Collaboration also
					helps advance the development of diagnostics, treatments and vaccines that will save lives and
					protect the health and safety of people everywhere. </p>
				<ul>
					<li>Canada has committed to <a
							href="https://www.canada.ca/en/global-affairs/news/2020/05/minister-gould-announces-funding-for-global-vaccinations.html">funding
							global vaccinations for COVID-19</a></li>
				</ul>
			</div>
			</div>

			<div id="def-preFooter">
			</div>
			<!-- Write closure template -->
			<script type="text/javascript">
				var defPreFooter = document.getElementById("def-preFooter");
				defPreFooter.outerHTML = wet.builder.preFooter({
					dateModified: "2020-03-13",
					showPostContent: true,
					showFeedback: true,
					showShare: true
				});
			</script>
	</main>
	<div id="def-footer">

	</div>
	<!-- Write closure template -->
	<script type="text/javascript">
		var defFooter = document.getElementById("def-footer");
		defFooter.outerHTML = wet.builder.footer({
			showFooter: true,
			showFeatures: true
		});
	</script>
	<!-- Write closure template -->
	<script type="text/javascript">
		document.write(wet.builder.refFooter({
		}));
	</script>
	<script src="https://test.canada.ca/covid-19-guidance/proto/js/contact-link-swap.js"></script>
	<script src="https://test.canada.ca/covid-19-guidance/proto/js/alpha-banner.js"></script>
</body>

</html>